|
Comprehensive genomic profiling in FIGHT-202 reveals the landscape of actionable alterations in advanced cholangiocarcinoma. |
|
|
|
Stock and Other Ownership Interests - Incyte |
|
|
Employment - Foundation Medicine |
Research Funding - Foundation Medicine |
Patents, Royalties, Other Intellectual Property - Koninklijke Philips NV |
Travel, Accommodations, Expenses - Foundation Medicine |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Incyte |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche |
|
|
|
|
Stock and Other Ownership Interests - Incyte |
Travel, Accommodations, Expenses - Incyte |
|
|
|
Stock and Other Ownership Interests - Incyte |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
|
Stock and Other Ownership Interests - Incyte |